Aristides Capital’s Tricida, Inc. Common Stock TCDA Stock Holding History

Aristides Capital’s Portfolio TCDA Stock Details TCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,887	Closed	-$183K	–	190
2020 Q4	$183K	Buy	+25,887	New	+$199K	0.06%	135

Other funds holding TCDA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Aristides Capital's TCDA Position: Q1 2021 in Review

Aristides Capital sold out of Tricida, Inc. Common Stock (TCDA) in Q1 2021, closing a stake of 25,887 shares — an estimated $183K sold.

Aristides Capital first reported a position in TCDA in Q4 2020 and held it in 1 quarter. The position peaked at $183K in Q4 2020. 104 funds tracked by Wall St. Rank hold TCDA as of Q1 2021.

Aristides Capital reported no remaining Tricida, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Aristides Capital sold 25,887 Tricida, Inc. Common Stock shares in Q1 2021, an estimated $183K.
Aristides Capital first reported a position in Tricida, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Aristides Capital's Tricida, Inc. Common Stock position peaked at $183K in Q4 2020.
104 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q1 2021.

Based on Aristides Capital's 13F filing for Q1 2021, filed 17 May 2021.